文献速递认知障碍与痴呆帕金森病与运动障碍神经免疫

视觉何在?神经系统疾病中视觉结局的重要性:2021年H. Houston Merritt讲座

Where's the Vision? The Importance of Visual Outcomes in Neurologic Disorders: The 2021 H. Houston Merritt Lecture.
PubMed 文献 · Neurology · 2022-12-15

本综述指出约50%的脑通路服务于视觉的传入和传出方面,强调视觉系统在神经系统疾病诊断与监测中的重要性。文章回顾了过去30年及更长时间内开发的视觉「工具箱」,用于捕捉多发性硬化、脑震荡、帕金森病及阿尔茨海默病谱系等疾病中视觉的结构与功能方面。综述以一例患者病例研究开始,强调使用包括光学相干断层扫描在内的最现代技术评估视觉通路的重要性,并强调结构和功能视觉测试工具可并行使用以检测亚临床事件或视觉及可能更全局的神经功能衰退的标志物。

要点

  • 约50%的脑通路服务于视觉的传入和传出方面
  • 视觉「工具箱」可捕捉多发性硬化、脑震荡、帕金森病及阿尔茨海默病谱系中视觉的结构与功能方面
  • 结构和功能视觉测试工具可并行使用以检测亚临床事件或视觉及可能更全局的神经功能衰退的标志物

核心结论

  • 视觉系统的结构和功能评估工具应并行使用,以检测神经系统疾病中可能亚临床的视觉事件或视觉及可能更全局的神经功能衰退的标志物。
  • 随着神经系统疾病谱系中临床试验和治疗的可及性增加,这些视觉测量措施将至关重要。

研究设计与样本

  • 本综述为2021年H. Houston Merritt讲座,回顾了过去30年及更长时间内开发的用于神经系统疾病视觉评估的结构和功能工具。
  • 综述以一例患者病例研究开始,强调使用包括光学相干断层扫描在内的最现代技术评估视觉通路的重要性。

主要发现

  • 约50%的脑通路服务于视觉的传入和传出方面。
  • 过去30年,研究者和临床医生已将视觉系统研究扩展到多发性硬化、脑震荡、帕金森病以及阿尔茨海默病谱系(阿尔茨海默病、轻度认知障碍和主观认知下降)等特定神经系统疾病患者。
  • 21世纪初以多发性硬化开始加速强调神经系统疾病中结构-功能关系,此类研究已扩展到认识到需要在神经系统疾病谱系的治疗临床试验中纳入视觉通路结构、功能和生活质量的结局。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neurologists have long recognized the importance of the visual system in the diagnosis and monitoring of neurologic disorders. This is particularly true because approximately 50% of the brain's pathways subserve afferent and efferent aspects of vision. During the past 30 years, researchers and clinicians have further refined this concept to include investigation of the visual system for patients with specific neurologic diagnoses, including multiple sclerosis (MS), concussion, Parkinson disease (PD), and conditions along the spectrum of Alzheimer disease (AD, mild cognitive impairment, and subjective cognitive decline). This review highlights the visual "toolbox" that has been developed over the past 3 decades and beyond to capture both structural and functional aspects of vision in neurologic disease. Although the efforts to accelerate the emphasis on structure-function relationships in neurologic disorders began with MS during the early 2000s, such investigations have broadened to recognize the need for outcomes of visual pathway structure, function, and quality of life for clinical trials of therapies across the spectrum of neurologic disorders. This review begins with a patient case study highlighting the importance using the most modern technologies for visual pathway assessment, including optical coherence tomography. We emphasize that both structural and functional tools for vision testing can be used in parallel to detect what might otherwise be subclinical events or markers of visual and, perhaps, more global neurologic decline. Such measures will be critical because clinical trials and therapies become more available across the neurologic disease spectrum.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Patil SA, Grossman S, Kenney R, et al. Where's the Vision? The Importance of Visual Outcomes in Neurologic Disorders: The 2021 H. Houston Merritt Lecture. Neurology. 2022. PMID: 36522160. doi:10.1212/WNL.0000000000201490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。